Encompass Health Corporation (EHC)

Market Cap	10.11B +0.2%
Revenue (ttm)	5.94B +10.5%
Net Income	564.70M +24.2%
EPS	5.54 +24.2%
Shares Out	99.42M
PE Ratio	18.37
Forward PE	17.18
Dividend	$0.76 (0.75%)
Ex-Dividend Date	Apr 1, 2026

Volume	606,967
Open	102.27
Previous Close	101.43
Day's Range	99.81 - 103.56
52-Week Range	92.77 - 127.99
Beta	0.56
Analysts	Strong Buy
Price Target	143.29 (+40.91%)
Earnings Date	Apr 23, 2026

About EHC

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary cond...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Sep 30, 1986
• Employees: 42,300
• Stock Exchange: NYSE
• Ticker Symbol: EHC
• Website: https://www.encompasshealth.com

Financial Performance

In 2025, Encompass Health's revenue was $5.94 billion, an increase of 10.46% compared to the previous year's $5.37 billion. Earnings were $564.70 million, an increase of 24.69%.

Analyst Summary

According to 7 analysts, the average rating for EHC stock is "Strong Buy." The 12-month stock price target is $143.29, which is an increase of 40.91% from the latest price.

Price Target

$143.29

(40.91% upside)

Analyst Consensus: Strong Buy